Express Scripts, CVS Caremark and OptumRx together control 59.2% of the pharmacy benefits market, according to data the American Medical Association published this month.

CVS Caremark, Express Scripts and Optum Rx are fighting back. After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of engaging in anticompetitive rebating ...

A CVS Caremark spokesman said it is “proud of the work we have done to make insulin more affordable for all Americans with diabetes. To suggest anything else, as the FTC did today, is simply wrong.

The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices” as it relates to insulin. One legal ...

FTC sues major pharmacy benefit managers over insulin prices The agency brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating ...

A landmark trial on board oversight ends abruptly as Meta leaders settle multibillion-dollar lawsuit over privacy lapses.

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...

CVS Caremark said in a statement that it has "led the way in driving down the cost of insulin for all patients: insured, uninsured and underinsured," adding that its members pay an average of less ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

The FTC claims CVS Health's Caremark, Cigna's ESI, United Health Group's OptumRx created a "perverse drug rebate system," resulting in higher insulin list prices. Even when lower list-price ...